Virbac's Strategic Acquisition: Expanding Horizons in Türkiye

In the ever-evolving landscape of animal health, Virbac, a global leader in the field, has made a strategic move to strengthen its presence in Türkiye. The company has recently acquired Mopsan, its companion animal products distributor, marking a significant step towards expanding its offerings and solidifying its position in the Turkish market. This acquisition not only brings valuable expertise but also aligns with Virbac's long-term vision for growth and stability.



Mopsan's extensive experience in the petfood and companion animal health products sector spans over three decades. With a team of 47 talented employees, the company has cultivated strong ties with local veterinarians, providing Virbac with a wealth of knowledge and connections to tap into. The acquisition of Mopsan allows Virbac to enhance its proximity to the field, better serving the growing animal health market in Türkiye.

A key aspect of this acquisition is the appointment of Alican İngeç, the former owner and managing director of Mopsan, as the managing director of Virbac's activities in Türkiye. With his deep understanding of the local market and extensive experience, İngeç will play a pivotal role in driving Virbac's growth in the region. This strategic move underscores Virbac's commitment to 'boring but lucrative' investments, prioritizing stability and predictable growth over short-term excitement.



Virbac's acquisition of Mopsan builds on its recent strategic acquisitions, including iVet in the US and Sasaeah in Japan. This trend reflects the company's long-term vision of expanding its petfood and animal health footprint worldwide. By leveraging Mopsan's expertise in the Turkish market, Virbac is well-positioned to navigate the fast-growing sector, driving consistent growth and reinforcing its leadership in the animal health industry.

In conclusion, Virbac's acquisition of Mopsan is a strategic move that aligns with the company's core investment values. By prioritizing stability, predictability, and consistent growth, Virbac has once again demonstrated its commitment to 'boring but lucrative' investments. With its eyes set on the future, the company continues to make strategic acquisitions and partnerships that support its enduring business model and solidify its position in the global animal health market.